SCHEMBL12422007

SCHEMBL12422007

Cc1ccc2nc(-c3ccc(NC(=O)c4ccc(OCC(F)(F)F)cc4)cc3)sc2c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.65
LMNA P02545 1/20 0.65
TP53 P04637 7/20 0.63
SMN1; SMN2 Q16637 9/20 0.61
THRB P10828 2/20 0.56
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 3/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HPGD P15428 2/20 0.53
RXFP1 Q9HBX9 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
POLB P06746 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
RORC P51449 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422001 0.91 MAPT (0.63) MAPTLMNATP53SMN1; SMN2THRB
SCHEMBL2191674 0.91 MAPT (0.56) MAPTLMNATP53SMN1; SMN2NPC1
SCHEMBL12422000 0.90 MAPT (0.62) MAPTLMNATP53SMN1; SMN2THRB
SCHEMBL2194068 0.90 SULT1A1 (0.57) MAPTLMNATP53SMN1; SMN2NPC1
SCHEMBL12422014 0.88 MAPT (0.66) MAPTLMNATP53SMN1; SMN2THRB
SCHEMBL12421986 0.88 MAPT (0.68) MAPTLMNATP53SMN1; SMN2THRB
SCHEMBL12421989 0.87 TP53 (0.71) MAPTLMNATP53SMN1; SMN2NPC1
SCHEMBL12421979 0.84 MAPT (0.68) MAPTLMNATP53SMN1; SMN2THRB
SCHEMBL12422009 0.83 MAPT (0.73) MAPTLMNATP53SMN1; SMN2NPC1
SCHEMBL12963239 0.82 MAPT (0.74) MAPTLMNATP53SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 MAPT 1/4885LMNA 2458/4885TP53 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.